Immuneering (IMRX) Change in Acquisitions & Divestments (2022 - 2024)
Historic Change in Acquisitions & Divestments for Immuneering (IMRX) over the last 3 years, with Q4 2024 value amounting to $5.5 million.
- Immuneering's Change in Acquisitions & Divestments fell 7112.86% to $5.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $31.9 million, marking a year-over-year decrease of 3894.84%. This contributed to the annual value of $31.9 million for FY2024, which is 3894.84% down from last year.
- As of Q4 2024, Immuneering's Change in Acquisitions & Divestments stood at $5.5 million, which was down 7112.86% from $5.0 million recorded in Q2 2024.
- In the past 5 years, Immuneering's Change in Acquisitions & Divestments registered a high of $32.3 million during Q2 2022, and its lowest value of $5.0 million during Q3 2023.
- Over the past 3 years, Immuneering's median Change in Acquisitions & Divestments value was $19.0 million (recorded in 2023), while the average stood at $16.1 million.
- As far as peak fluctuations go, Immuneering's Change in Acquisitions & Divestments plummeted by 7402.6% in 2023, and later soared by 1278.95% in 2024.
- Quarter analysis of 3 years shows Immuneering's Change in Acquisitions & Divestments stood at $20.6 million in 2022, then decreased by 7.52% to $19.0 million in 2023, then tumbled by 71.13% to $5.5 million in 2024.
- Its Change in Acquisitions & Divestments stands at $5.5 million for Q4 2024, versus $5.0 million for Q2 2024 and $21.4 million for Q1 2024.